Medicine guide
Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml
As listed in the register: Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml, Injektionslösung
3.6 mg/ml ·
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Insulinum degludecum + Liraglutidum
- Made by
- Novo Nordisk Pharma AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Diabetes mellitus bei Erwachsenen
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | Novo Nordisk Pharma AG |
|---|---|
| Active substance | Insulinum degludecum + Liraglutidum |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 3.6 mg/ml |
| Classification | A10AE56 · Digestion, stomach, diabetes and nutrition |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml, Injektionslösung |
| Packs | 3 x 3 ml |
| Zulassungsnummer | 65041 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.